SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 158 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $845,000 | -33.7% | 277,184 | +0.7% | 0.00% | -50.0% |
Q3 2016 | $1,275,000 | -20.2% | 275,389 | -0.2% | 0.00% | 0.0% |
Q2 2016 | $1,598,000 | +12.4% | 275,923 | +17.4% | 0.00% | 0.0% |
Q1 2016 | $1,422,000 | -32.7% | 235,000 | +1.5% | 0.00% | -33.3% |
Q4 2015 | $2,113,000 | +62.2% | 231,421 | +0.2% | 0.00% | +50.0% |
Q3 2015 | $1,303,000 | -49.9% | 231,058 | -1.4% | 0.00% | -33.3% |
Q2 2015 | $2,600,000 | -11.9% | 234,428 | +24.6% | 0.00% | -25.0% |
Q1 2015 | $2,950,000 | +4.9% | 188,129 | +1.7% | 0.00% | 0.0% |
Q4 2014 | $2,813,000 | +39.4% | 184,953 | -1.2% | 0.00% | +33.3% |
Q3 2014 | $2,018,000 | -28.9% | 187,138 | +0.7% | 0.00% | -25.0% |
Q2 2014 | $2,839,000 | -14.6% | 185,892 | +1.1% | 0.00% | -20.0% |
Q1 2014 | $3,325,000 | +43.5% | 183,894 | +10.2% | 0.01% | +66.7% |
Q4 2013 | $2,317,000 | +30.8% | 166,822 | -1.2% | 0.00% | 0.0% |
Q3 2013 | $1,771,000 | +57.7% | 168,872 | +17.4% | 0.00% | +50.0% |
Q2 2013 | $1,123,000 | – | 143,835 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rokos Capital Management LLP | 6,474,348 | $11,394,852 | 0.84% |
WASATCH ADVISORS LP | 13,642,417 | $24,010,654 | 0.15% |
Avidity Partners Management LP | 2,470,000 | $4,347,200 | 0.14% |
Acrisure Capital Management, LLC | 75,832 | $133,464 | 0.14% |
Golden State Equity Partners | 135,765 | $238,946 | 0.13% |
Long Focus Capital Management, LLC | 1,072,000 | $1,886,720 | 0.11% |
KLK CAPITAL MANAGEMENT LLC | 44,323 | $78,008 | 0.10% |
CAXTON ASSOCIATES LP | 288,218 | $507,264 | 0.08% |
XTX Topco Ltd | 206,334 | $363,148 | 0.08% |
Rhenman & Partners Asset Management AB | 314,157 | $534,067 | 0.06% |